Glucotrack shareholders approve reverse stock split (up to 1:100) and increase equity plan shares to 7.5M

Glucotrack, Inc.

• All five director nominees elected with ~59% of votes cast in favor; broker non-votes amounted to ~5.45M on each nominee.
• Reverse stock split authorized at a ratio not exceeding 1:100; management will determine exact ratio.
• Equity incentive plan share pool increased to 7.5 million shares from prior limit.
• Auditor Fahn Kanne & Co. Grant Thornton Israel ratified with ~91% of votes cast in favor.
• Quorum of 44.32% achieved with 11,339,896 shares represented at the meeting.